Subsequent studies revealed its role in inhibiting bone formation by regulating ATF4 [32] and promoting hepatic stellate cell activation by suppressing Sufu expression in non-alcoholic steatohepatitis [33], and so on. The gene discussed is ATF4; the disease is metabolic dysfunction-associated steatohepatitis.